Cargando…

Harnessing the Complete Repertoire of Conventional Dendritic Cell Functions for Cancer Immunotherapy

The onset of checkpoint inhibition revolutionized the treatment of cancer. However, studies from the last decade suggested that the sole enhancement of T cell functionality might not suffice to fight malignancies in all individuals. Dendritic cells (DCs) are not only part of the innate immune system...

Descripción completa

Detalles Bibliográficos
Autores principales:	Amon, Lukas, Hatscher, Lukas, Heger, Lukas, Dudziak, Diana, Lehmann, Christian H. K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7408110/ https://www.ncbi.nlm.nih.gov/pubmed/32674488 http://dx.doi.org/10.3390/pharmaceutics12070663

Ejemplares similares

XCR1 expression distinguishes human conventional dendritic cell type 1 with full effector functions from their immediate precursors
por: Heger, Lukas, et al.
Publicado: (2023)

CLEC10A Is a Specific Marker for Human CD1c(+) Dendritic Cells and Enhances Their Toll-Like Receptor 7/8-Induced Cytokine Secretion
por: Heger, Lukas, et al.
Publicado: (2018)

Direct Delivery of Antigens to Dendritic Cells via Antibodies Specific for Endocytic Receptors as a Promising Strategy for Future Therapies
por: Lehmann, Christian H. K., et al.
Publicado: (2016)

Editorial: Harnessing the Participation of Dendritic Cells in Immunity and Tolerance
por: Boscardin, Silvia Beatriz, et al.
Publicado: (2020)

Characterization and Manipulation of the Crosstalk Between Dendritic and Natural Killer Cells Within the Tumor Microenvironment
por: Jacobs, Benedikt, et al.
Publicado: (2021)

Subsets of CD1c(+) DCs: Dendritic Cell Versus Monocyte Lineage
por: Heger, Lukas, et al.
Publicado: (2020)

Impact of Plasma Membrane Domains on IgG Fc Receptor Function
por: Kara, Sibel, et al.
Publicado: (2020)

Analysis of dendritic cells in human lymphoid organs
por: Heidkamp, Gordon F, et al.
Publicado: (2012)

Harnessing the potential of radiation treatment of brain metastases to improve melanoma immunotherapy
por: McNeilly, Corey D, et al.
Publicado: (2015)

Monocyte-Derived Signals Activate Human Natural Killer Cells in Response to Leishmania Parasites
por: Messlinger, Helena, et al.
Publicado: (2018)

Loading of Primary Human T Lymphocytes with Citrate-Coated Superparamagnetic Iron Oxide Nanoparticles Does Not Impair Their Activation after Polyclonal Stimulation
por: Mühlberger, Marina, et al.
Publicado: (2020)

CXCR4 blockade reduces the severity of murine heart allograft rejection by plasmacytoid dendritic cell-mediated immune regulation
por: Fu, Jian, et al.
Publicado: (2021)

Maturation of Monocyte-Derived DCs Leads to Increased Cellular Stiffness, Higher Membrane Fluidity, and Changed Lipid Composition
por: Lühr, Jennifer J., et al.
Publicado: (2020)

Monocytes Elicit a Neutrophil-Independent Th1/Th17 Response Upon Immunization With a Mincle-Dependent Glycolipid Adjuvant
por: Desel, Christiane, et al.
Publicado: (2022)

Harnessing the Microbiome to Enhance Cancer Immunotherapy
por: Nelson, Michelle H., et al.
Publicado: (2015)

Dendritic Cell Vaccines for Cancer Immunotherapy: The Role of Human Conventional Type 1 Dendritic Cells
por: Calmeiro, João, et al.
Publicado: (2020)

Modulation of urelumab glycosylation separates immune stimulatory activity from organ toxicity
por: Reitinger, Carmen, et al.
Publicado: (2022)

Harnessing Human Cross-Presenting CLEC9A(+)XCR1(+) Dendritic Cells for Immunotherapy
por: Tullett, Kirsteen M., et al.
Publicado: (2014)

Harnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy
por: Mathan, Till S.M., et al.
Publicado: (2017)

Harnessing the antitumor potential of macrophages for cancer immunotherapy
por: Long, Kristen B, et al.
Publicado: (2013)

Harnessing Metabolic Reprogramming to Improve Cancer Immunotherapy
por: Yan, Liang, et al.
Publicado: (2021)

Cancer Immunotherapy: Harnessing the Immune System to Fight Cancer
por: Rizzo, Alessandro, et al.
Publicado: (2022)

BCL2 inhibition reveals a dendritic cell-specific immune checkpoint that controls tumor immunosurveillance
por: Zhao, Liwei, et al.
Publicado: (2023)

Harnessing tumor-associated macrophages as aids for cancer immunotherapy
por: Li, Xiaolei, et al.
Publicado: (2019)

Harnessing Antitumor CD4(+) T Cells for Cancer Immunotherapy
por: Ben Khelil, Myriam, et al.
Publicado: (2022)

Harnessing the Immunological Effects of Radiation to Improve Immunotherapies in Cancer
por: Hannon, Gary, et al.
Publicado: (2023)

Frenemies in the Microenvironment: Harnessing Mast Cells for Cancer Immunotherapy
por: Sulsenti, Roberta, et al.
Publicado: (2023)

Harnessing epithelial-mesenchymal plasticity to boost cancer immunotherapy
por: Gu, Yuanzhuo, et al.
Publicado: (2023)

Harnessing Unconventional T Cells for Immunotherapy of Tuberculosis
por: La Manna, Marco P., et al.
Publicado: (2020)

Harnessing neutrophil plasticity for HCC immunotherapy
por: Ramon-Gil, Erik, et al.
Publicado: (2023)

Rational Vaccinology: Harnessing Nanoscale Chemical Design for Cancer Immunotherapy
por: Huang, Ziyin, et al.
Publicado: (2022)

Harnessing dendritic cells in inflammatory skin diseases
por: Chu, Chung-Ching, et al.
Publicado: (2011)

Harnessing Dendritic Cells for Tumor Antigen Presentation
por: Nierkens, Stefan, et al.
Publicado: (2011)

Environmental signals rather than layered ontogeny imprint the function of type 2 conventional dendritic cells in young and adult mice
por: Papaioannou, Nikos E., et al.
Publicado: (2021)

The Effect of Hyperthermia and Radiotherapy Sequence on Cancer Cell Death and the Immune Phenotype of Breast Cancer Cells
por: Sengedorj, Azzaya, et al.
Publicado: (2022)

T-Cell Receptor Repertoire Sequencing in the Era of Cancer Immunotherapy
por: Frank, Meredith L., et al.
Publicado: (2023)

Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy
por: Subhash, Vinod Vijay, et al.
Publicado: (2015)

Harnessing immunosurveillance: current developments and future directions in cancer immunotherapy
por: Drakes, Maureen L, et al.
Publicado: (2014)

Harnessing the Power of Invariant Natural Killer T Cells in Cancer Immunotherapy
por: Bedard, Melissa, et al.
Publicado: (2017)

Harnessing nanomedicine for enhanced immunotherapy for breast cancer brain metastases
por: Carney, Christine P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_dr0rbn0k6l2r7kgg3jejc1crv9